Evidence map›Paper›PMID 21369831›Full record

ArticleJournal of genetic counseling2011

Development and evaluation of a decision aid for BRCA carriers with breast cancer.

Julie O Culver, Deborah J MacDonald, Andrea A Thornton, Sharon R Sand, Marcia Grant, Deborah J Bowen, Harry Burke, Nellie Garcia, Kelly A Metcalfe, Jeffrey N Weitzel

Erratum issuedAbstract read
In one paragraph

Article in Journal of genetic counseling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Decision Aids for Preventive Treatment Alternatives forGeburtshilfe und Frauenheilkunde · 2021
    Article
  12. Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  13. Review
  14. Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  15. Decision aid prototype development for parents considering adenotonsillectomy for their children with sleep disordered breathing.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors.

Julie O CulverDivision of Clinical Cancer Genetics, Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA 91010-3000, USA. jculver@coh.org
Deborah J MacDonald
Andrea A Thornton
Sharon R Sand
Marcia Grant
Deborah J Bowen
Harry Burke
Nellie Garcia
Kelly A Metcalfe
Jeffrey N Weitzel

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
NCI NIH HHS P30 CA033572NCI NIH HHS P30CA033572NCRR NIH HHS M01 RR000043NCRR NIH HHS M01 RR00043
6 · The paper itself

Abstract

BRCA+ breast cancer patients face high risk for a second breast cancer and ovarian cancer. Helping these women decide among risk-reducing options requires effectively conveying complex, emotionally-laden, information. To support their decision-making needs, we developed a web-based decision aid (DA) as an adjunct to genetic counseling. Phase 1 used focus groups to determine decision-making needs. These findings and the Ottawa Decision Support Framework guided the DA development. Phase 2 involved nine focus groups of four stakeholder types (BRCA+ breast cancer patients, breast cancer advocates, and genetics and oncology professionals) to evaluate the DA's decision-making utility, information content, visual display, and implementation. Overall, feedback was very favorable about the DA, especially a values and preferences ranking-exercise and an output page displaying personalized responses. Stakeholders were divided as to whether the DA should be offered at-home versus only in a clinical setting. This well-received DA will be further tested to determine accessibility and effectiveness.

Indexed as

Decision Support TechniquesGenes, BRCA1Genes, BRCA2Genetic Carrier ScreeningBreast NeoplasmsFemaleFocus GroupsGenetic CounselingHumansMastectomyOvariectomyRisk Reduction Behavior

Identifiers

PMID21369831
PMCPMC3531556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.